Digital health advisory case studies

Real-world digital health strategy, market expansion, and due diligence work

Explore how Galen Growth helps healthcare leaders, investors, insurers, pharmaceutical companies, medical device teams, and public-sector organisations move from fragmented market signals to decision-grade digital health intelligence.

Hundredsof projects delivered

6client sectors

3,000+ventures evaluated in selected cases

30+markets covered

Use cases

Where our digital health intelligence is applied

Each engagement is powered by HealthTech Alpha and shaped by analyst interpretation so the output is usable in board, strategy, investment, market access, and partnership decisions.

Market expansion

Prioritise geographies, ecosystems, access pathways, and venture categories before committing capital or commercial focus.

Due diligence

Screen, benchmark, and validate ventures before investment, acquisition, partnership, or market access decisions.

Competitive intelligence

Track competitor moves, partnership patterns, product signals, and market positioning across digital health categories.

Portfolio risk stratification

Assess exposure, duplication, readiness, governance gaps, and evidence strength across digital health portfolios.

Health innovation strategy

Turn fragmented health innovation signals into decision-ready roadmaps for pharma, medtech, insurers, investors, and health systems.

Market access intelligence

Evaluate reimbursement, adoption, evidence, partnership, and ecosystem constraints that shape commercialisation.

Selected work

Case studies across the digital health decision lifecycle

Filter by client sector, business vertical, or ecosystem to find relevant examples of Galen Growth work.

Business Verticals Market Expansion Due Diligence Competitive Intelligence Portfolio Risk Stratification Health Innovation Strategy Market Access Intelligence

Ecosystems Asia Pacific Europe Latin America North America

Biopharma

Real World Evidence in China

As part of a full franchise strategy review, a leading pharmaceutical company was looking to evaluate its global portfolio of existing partnerships with Digital Health ventures to confirm…

Solution: Portfolio Risk Stratification
Markets: Asia Pacific

Read case study

Insurance

Sourcing Digital Health for non-fluid underwriting

A global re-insurer wanted to identify mature ventures across non-fluid underwriting, digital biomarkers, digital therapeutics, genomics and teleconsultation

Solution: Ecosystem Mapping
Markets: North America

Read case study

Venture Capital

Competitive analysis in genomics for a reinsurance company

The Corporate Venture Capital (CVC) arm of a global reinsurance company wanted to, as part of their ongoing due diligence, undertake a global competitive analysis in the genomics…

Solution: Ecosystem Mapping, Health Innovation Strategy
Markets: Asia Pacific, Europe, North America

Read case study

Venture Capital

Macro and micro-environment analysis in RWD & RWE

The Corporate Venture Capital (CVC) arm of a global pharmaceutical company wanted to analyse a specific key APAC market to assess both the macro and micro-environment for Real…

Solution: Due Diligence, Ecosystem Mapping
Markets: Asia Pacific

Read case study

Medical Device

Shortlisting personal health ventures in key therapeutic areas

A global leading medical device company sought to understand the personal health Digital Health landscape for two priority therapeutic areas in key global ecosystems to identify and evaluate…

Solution: Due Diligence, Ecosystem Mapping
Markets: Europe, Latin America

Read case study

Biopharma

Key therapeutic area Digital Health portfolio evaluation

As part of a full franchise strategy review, a leading pharmaceutical company was looking to evaluate its global portfolio of existing partnerships with Digital Health ventures to confirm…

Solution: Portfolio Risk Stratification
Markets: Latin America

Read case study

Biopharma

Sourcing pan-omics focused ventures

A global biotech wanted to understand the pan-omics (e.g. proteomics) digital health landscape and ecosystems within two key regional ecosystems

Solution: Competitive Intelligence, Ecosystem Mapping
Markets: Europe, Latin America

Read case study

Biopharma

Shortlisting ventures for cardio remote monitoring

A global pharmaceutical wanted to shortlist and prioritise ventures which provided a solution with telemonitoring capabilities, that connects patients suffering from heart failure and physicians (cardiologists). Ventures of…

Solution: Ecosystem Mapping, Health Innovation Strategy
Markets: Europe

Read case study

Biopharma

Pinpointing oncology biomarker scoring algorithms

A global pharmaceutical wanted to identify and shortlist proven ventures that have developed a specific Digital biomarker scoring algorithm capability

Solution: Competitive Intelligence, Ecosystem Mapping
Markets: Latin America

Read case study

Insurance

Evaluating a corporate’s major competitors in Digital Health in Asia Pac

An APAC focused insurer wanted to analyse other insurers in the region, in order to identify their competitors key areas of focus, and determine a ‘follow’ or differentiation…

Solution: Competitive Intelligence, Health Innovation Strategy
Markets: Asia Pacific

Read case study

Insurance

Strategic Digital Health decision making and acceleration across Asia Pac

This global Insurer looked to accelerate its Digital Health footprint in Asia, prioritise markets for innovation, and scout for HealthTech ventures that met specific Therapeutic and Category objectives

Solution: Competitive Intelligence, Due Diligence
Markets: Asia Pacific

Read case study

Biopharma

Benchmarking Digital Health partnerships

Our client, a leading global biopharma, wanted monitor how biopharma is investing and operating in Digital Health across their value chain, to better support its own Digital Health…

Solution: Competitive Intelligence
Markets: North America

Read case study

Insurance

Sourcing Digital Health in OMICS

A Regional insurance company wanted to identify innovative solutions and business models within the OMICS realm that are tackling Oncology and Wellness.

Solution: Ecosystem Mapping, Market Access Intelligence
Markets: North America

Read case study

Medical Device

Shortlisting ventures for cardio remote monitoring

Our client, one of the major global medical device companies, wanted to identify digital health solutions across five markets: USA, France, Germany, UK and Italy. Their specific focus…

Solution: Ecosystem Mapping, Market Expansion
Markets: Europe

Read case study

Biopharma

Finding research solutions in Oncology

A large pharmaceutical player sought oncology ventures that could offer advice, patient cohorts, or clinical trials capabilities, in LATAM, Middle East & Asia

Solution: Ecosystem Mapping, Market Access Intelligence
Markets: Asia Pacific

Read case study

Biopharma

Market opportunity optimisation

A global pharma company specialized in women’s health wanted to analyse its priority markets in order to build the future roadmap of innovative solutions for women, starting from…

Solution: Competitive Intelligence, Ecosystem Mapping
Markets: Asia Pacific

Read case study

Biopharma

Tracking Competitor Moves to Support Global Franchise Strategy

How should we track competitor activity across obesity, diabetes and cardiovascular disease to support global strategic decisions?

Solution: Competitive Benchmarking, Structured Intelligence Programme
Markets: United States, EU5, United Kingdom

Read case study

Biopharma

Prioritising Markets and Partners to Accelerate a Women’s Health Roadmap

Which priority markets and venture partners should anchor our future women’s health innovation roadmap, starting with telemedicine?

Solution: Digital Health Readiness Assessment, Structured Partner Scouting
Markets: South Korea, Spain, United States

Read case study

Insurance

Sourcing OMICS Ventures to Shape Oncology and Wellness Strategy

Which OMICS-led ventures tackling oncology and wellness are mature enough to partner with an enterprise insurer?

Solution: Next-Gen Scouting, Comparative Ecosystem Mapping
Markets: United States, Israel, United Kingdom

Read case study

Biopharma

Benchmarking Global Competitor Partnerships to Prioritise Digital Health Strategy

Where are competitors investing and partnering in Digital Health, and what should that mean for our own portfolio strategy?

Solution: Competitive Benchmarking, Partnership Relevance Scoring
Markets: United States, Europe, Israel

Read case study

Biopharma

Informing Franchise-Level Resource Allocation Across APAC

Which APAC markets should we prioritise for Digital Health investment, and where is our franchise readiness strongest?

Solution: Digital Health Readiness Assessment, Next-Gen Scouting
Markets: Asia-Pacific

Read case study

Biopharma

Pinpointing Oncology Ventures with Clinical Trial Capability in Emerging Markets

Which oncology ventures in emerging markets can offer advice, patient cohorts or clinical trial capability at scale?

Solution: Next-Gen Scouting, Clinical Trials Ecosystem Mapping
Markets: Latin America, Middle East, Asia-Pacific

Read case study

Medical Device

Selecting Cardiac Remote Monitoring Partners for Personalised Patient Care

Which cardiac remote monitoring ventures are mature enough to support personalised patient care across our priority markets?

Solution: Next-Gen Scouting, Venture Fit Scoring
Markets: United States, France, Germany

Read case study

Insurance

Sourcing HealthTech Ventures to Power Non-Fluid Underwriting

Which ventures across digital biomarkers, DTx, genomics and teleconsultation are mature enough to enable non-fluid underwriting?

Solution: Next-Gen Scouting, Comparative Ecosystem Mapping
Markets: United States, Canada

Read case study

Insurance

Pressure-Testing a Digital Health Partnership Before Commitment

How does our preferred venture partner compare against credible alternatives in the same market and therapeutic focus?

Solution: Competitive Benchmarking, Similarity Index Analysis
Markets: United States, China

Read case study

Insurance

Helping an APAC Insurer Prioritise Markets, Categories and Venture Targets

Which APAC markets, therapeutic areas and Digital Health categories should we prioritise to accelerate regional growth?

Solution: Digital Health Readiness Assessment, Competitive Benchmarking
Markets: Asia-Pacific

Read case study

Insurance

Mapping Competitor Moves to Set a Differentiated APAC Strategy

Where are our regional competitors investing in Digital Health, and should we follow or differentiate?

Solution: Competitive Benchmarking, Partnership Heat-Mapping
Markets: Asia-Pacific

Read case study

Biopharma

Identifying Ventures With Proven Digital Biomarker Scoring Capability

Which ventures have a proven, differentiated digital biomarker scoring algorithm in oncology?

Solution: Competitive Benchmarking, Next-Gen Scouting
Markets: United States, Japan, Israel

Read case study

Biopharma

Shortlisting GDPR-Ready Telemonitoring Ventures for Heart Failure

Which telemonitoring ventures can credibly connect heart-failure patients with cardiologists and meet our eight enterprise criteria?

Solution: Next-Gen Scouting, Venture Fit Scoring
Markets: France, Adjacent European markets

Read case study

Biopharma

Decoding the Pan-Omics Venture Landscape Across Europe and Asia

Where is pan-omics innovation concentrated across Europe and Asia, and which ventures warrant deeper engagement?

Solution: Next-Gen Scouting, Strategic Partnership Mapping
Markets: Priority European ecosystems, Priority Asian ecosystems

Read case study

Medical Device

Selecting Personal Health Ventures for Two Priority Therapeutic Areas

Which personal-health ventures are the optimal fit for our two priority therapeutic areas across the major global ecosystems?

Solution: Next-Gen Scouting, Comparative Venture Evaluation
Markets: United States, Europe, Israel

Read case study

Biopharma

Pressure-Testing an Existing Digital Health Portfolio for Fitness to Scale

Is our existing Digital Health portfolio fit for purpose against our updated franchise strategy?

Solution: Portfolio Evaluation, Operational Maturity Scoring
Markets: Global priority ecosystems, United States, Israel

Read case study

Venture Capital

Mapping the Real-World Evidence Landscape in China for an Investor Thesis

Is real-world evidence in China a defensible thesis, and which ventures are emerging as category leaders?

Solution: Real-World Evidence Landscape Review, Venture Diligence Support
Markets: China

Read case study

Biopharma

Building a Startup Bridge in APAC for HPV, Cervical Cancer and Immuno-Oncology

Which APAC Digital Health ventures can help us drive HPV awareness, cervical cancer action and immuno-oncology innovation?

Solution: Next-Gen Scouting, Digital Health Readiness Assessment
Markets: Asia-Pacific

Read case study

Public Sector

Benchmarking Singapore’s Digital Health Ecosystem Against Global Peers

How does Singapore’s Digital Health ecosystem compare globally, and where should national policy and investment focus?

Solution: Ecosystem Benchmarking, Policy and Investment Advisory
Markets: Singapore

Read case study

Decision-grade intelligence

Digital health advisory grounded in structured market evidence

Galen Growth combines HealthTech Alpha data with expert analysis to support digital health market expansion, competitive intelligence, market access strategy, portfolio risk stratification, partner identification, and transaction due diligence.

Our work is designed for teams that need traceable intelligence, not generic research: pharmaceutical innovation teams, medical device strategy groups, insurers, health systems, investors, corporate venture teams, and public-sector health innovation leaders.